Dupixent® (dupilumab) Approved in China as the First-ever Biologic Medicine for Patients with Chronic Obstructive Pulmonary Disease (COPD)
September 27, 2024 07:00 ET
|
Regeneron Pharmaceuticals, Inc.
Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils, and is based on two landmark Phase 3 trials showing Dupixent significantly reduced exacerbations, improved...
Jianzhi Education Technology Group Company Limited Reports Half Year 2024 Financial Results
September 27, 2024 07:00 ET
|
Jianzhi Education Technology Group Company Limited
BEIJING, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Jianzhi Education Technology Group Company Limited (the “Company” or “Jianzhi”) (NASDAQ: JZ), a leading provider of digital educational content in China,...
Tonix Pharmaceuticals Announces Issuance of U.S. Patent Covering the Subcutaneous Delivery of FDA-Approved Zembrace® SymTouch® to Treat Migraines
September 27, 2024 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
New patent expected to provide market exclusivity into 2036 Zembrace® SymTouch® (sumatriptan succinate injection) 10mg is indicated for the acute treatment of migraine in adults CHATHAM, N.J., Sept....
Lyra Therapeutics to Present Study Results for LYR-210 and LYR-220 in Two Presentations at the ARS and AAO-HNS Annual Meetings
September 27, 2024 07:00 ET
|
Lyra Therapeutics
WATERTOWN, Mass., Sept. 27, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA), (“Lyra” or the “Company”), a clinical-stage biotechnology company developing long-acting...
Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes
September 27, 2024 06:57 ET
|
Aclarion, Inc.
Modic Changes (MC) are MRI Findings Associated With Endplate Damage, Neoinnervation, and Chronic Low Back Pain (cLBP) MR Spectroscopy (MRS) Measurement of Intradiscal Propionic Acid (PA) can Clarify...
Join Nova Minerals’ Exclusive Live Investor Webinar and Q&A Session on October 7
September 27, 2024 06:30 ET
|
NOVA MINERALS LIMITED
Caulfield, Australia, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Nova Minerals Limited (“Nova” or the “Company”) (NASDAQ: NVA) (ASX: NVA) (FRA: QM3), is pleased to invite investors to a webinar on October...
Informations sur le nombre total de droits de vote et d'actions
September 27, 2024 02:05 ET
|
Nyxoah
INFORMATION RÉGLEMENTÉE Informations sur le nombre total de droits de vote et d'actions Mont-Saint-Guibert (Belgique), le 27 septembre 2024, 8:05 CET / 2:05h ET – Conformément à l'article 15 de la...
Information on the total number of voting rights and shares
September 27, 2024 02:05 ET
|
Nyxoah
REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), September 27, 2024, 08:05 am CET / 2:05 am ET – In accordance with article 15 of the...
Publication relative à des notifications de transparence
September 27, 2024 02:00 ET
|
Nyxoah
INFORMATION RÉGLEMENTÉE Publication relative à des notifications de transparence Mont-Saint-Guibert (Belgique), le 27 septembre 2024, 08:00h CET / 2:00h ET – Conformément à l'article 14 de la...
Publication relating to transparency notifications
September 27, 2024 02:00 ET
|
Nyxoah
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), September 27, 2024, 8.00am CET / 2.00am ET – In accordance with article 14 of...